XML 127 R103.htm IDEA: XBRL DOCUMENT v3.24.0.1
Notes to the Balance Sheet - Summary of Development Funding Bond - Additional Information (Details)
$ in Millions
Dec. 31, 2023
EUR (€)
Dec. 31, 2023
USD ($)
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Dec. 31, 2021
USD ($)
Financial Liabilities Royalty Pharma [Line Items]          
Market interest rate     7.50% 6.30% 6.30%
Financial Liabilities from Future Payments to Royalty Pharma € 119,811,363   € 102,171,167    
Development Funding Bond          
Financial Liabilities Royalty Pharma [Line Items]          
Borrowings, interest rate 13.30% 13.30%   13.30% 13.30%
Financial Liabilities from Future Payments to Royalty Pharma € 8,784,000   € 0    
Addition 56,700,000 $ 57.6      
Development Funding Bond | Bottom of range          
Financial Liabilities Royalty Pharma [Line Items]          
Cash payments development funding bond       € 147,700,000 $ 150.0
Royalty purchase agreement          
Financial Liabilities Royalty Pharma [Line Items]          
Financial Liabilities from Future Payments to Royalty Pharma € 58,400,000 $ 69.0